Dr. Henry Beecher, M.D

NPI: 1396949582
Total Payments
$19,159
2024 Payments
$3,164
Companies
49
Transactions
1,009
Medicare Patients
2,639
Medicare Billing
$280,793

Payment Breakdown by Category

Food & Beverage$19,146 (99.9%)
Education$12.87 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $19,146 1,005 99.9%
Education $12.87 2 0.1%
Unspecified $0 2 0.0%

Payments by Type

General
$19,159
1,007 transactions
Ownership
$0
2 transactions

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $4,010 234 $0 (2024)
ABBVIE INC. $3,716 180 $0 (2024)
Janssen Biotech, Inc. $1,689 80 $0 (2024)
PFIZER INC. $1,405 85 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $1,306 66 $0 (2024)
Gilead Sciences, Inc. $795.87 45 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $667.55 38 $0 (2024)
Allergan, Inc. $432.72 30 $0 (2020)
Valeant Pharmaceuticals North America LLC $401.06 18 $0 (2017)
Celgene Corporation $391.24 16 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,164 137 ABBVIE INC. ($633.32)
2023 $2,641 131 AbbVie Inc. ($612.24)
2022 $2,974 153 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($874.16)
2021 $2,415 133 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($758.28)
2020 $1,791 106 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($601.29)
2019 $2,221 132 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($737.84)
2018 $2,007 108 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($546.83)
2017 $1,945 109 Valeant Pharmaceuticals North America LLC ($401.06)

All Payment Transactions

1,009 individual payment records from CMS Open Payments — Page 1 of 41

Date Company Product Nature Form Amount Type
12/17/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $31.44 General
Category: LIVER DISEASE
12/13/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $23.93 General
Category: Immunology
12/12/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $32.92 General
Category: Rare Disease
12/12/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $15.39 General
Category: GASTROENTEROLOGY
12/11/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $24.85 General
Category: IMMUNOLOGY
12/11/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $14.29 General
Category: THERAPY FOR CSID
12/10/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $21.35 General
Category: Immunology
12/10/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $14.09 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/10/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $1.07 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/04/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $33.32 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
12/04/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $24.97 General
Category: GASTROENTEROLOGY
12/03/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $23.15 General
Category: GASTROENTEROLOGY
12/02/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $38.35 General
Category: LIVER DISEASE
11/27/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $33.40 General
Category: Rare Disease
11/19/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $7.42 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/13/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $20.28 General
11/12/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $18.18 General
11/06/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $22.31 General
Category: IMMUNOLOGY
11/04/2024 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $26.66 General
Category: ENDOCRINOLOGY
11/01/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $23.24 General
Category: GASTROENTEROLOGY
10/30/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $27.68 General
Category: Oncology
10/29/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $26.06 General
Category: Immunology
10/23/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $27.11 General
Category: INTERNAL MEDICINE
10/22/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $29.08 General
Category: GASTROENTEROLOGY
10/17/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $20.79 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 573 612 $223,989 $64,035
2022 11 619 684 $192,494 $68,141
2021 12 857 941 $253,014 $94,117
2020 10 590 653 $151,698 $54,501
Total Patients
2,639
Total Services
2,890
Medicare Billing
$280,793
Procedure Codes
43

All Medicare Procedures & Services

43 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 91 92 $65,603 $19,330 29.5%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 112 113 $57,558 $8,176 14.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 91 91 $42,410 $7,873 18.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 78 89 $10,035 $5,943 59.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 38 38 $9,227 $5,215 56.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 60 60 $9,936 $4,861 48.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 36 39 $7,497 $3,883 51.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 34 57 $4,942 $3,432 69.4%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 16 16 $8,907 $2,837 31.9%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 17 17 $7,874 $2,486 31.6%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 75 75 $43,413 $15,245 35.1%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 90 90 $31,423 $9,237 29.4%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 127 128 $56,590 $8,942 15.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 56 57 $13,364 $8,924 66.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 83 112 $11,127 $7,634 68.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 55 86 $6,744 $4,842 71.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 52 52 $6,317 $3,710 58.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 33 36 $5,044 $3,281 65.0%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 15 15 $5,795 $2,764 47.7%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 19 19 $11,063 $2,430 22.0%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 14 14 $1,615 $1,132 70.1%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 83 83 $42,826 $17,233 40.2%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 124 124 $62,074 $12,844 20.7%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 149 149 $18,063 $12,245 67.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 123 152 $14,969 $10,325 69.0%

About Dr. Henry Beecher, M.D

Dr. Henry Beecher, M.D is a Gastroenterology healthcare provider based in Stamford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396949582.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Beecher, M.D has received a total of $19,159 in payments from pharmaceutical and medical device companies, with $3,164 received in 2024. These payments were reported across 1,009 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($19,146).

As a Medicare-enrolled provider, Beecher has provided services to 2,639 Medicare beneficiaries, totaling 2,890 services with total Medicare billing of $280,793. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Gastroenterology
  • Location Stamford, CT
  • Active Since 06/12/2007
  • Last Updated 07/08/2007
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1396949582

Products in Payments

  • XIFAXAN (Drug) $3,110
  • XELJANZ (Drug) $1,389
  • LINZESS (Drug) $912.48
  • STELARA (Biological) $863.84
  • RINVOQ (Biological) $752.03
  • ENTYVIO (Biological) $733.19
  • TRULANCE (Drug) $609.65
  • REMICADE (Biological) $596.53
  • HUMIRA (Biological) $559.85
  • Linzess (Drug) $519.83
  • CREON (Drug) $494.55
  • XIFAXANIBSD (Drug) $429.78
  • Creon (Drug) $392.38
  • ZEPOSIA (Drug) $391.24
  • Talicia (Drug) $368.26
  • Entyvio (Biological) $363.74
  • ZENPEP (Drug) $359.19
  • VIBERZI (Drug) $328.06
  • VOQUEZNA (Drug) $310.80
  • SKYRIZI (Biological) $282.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Stamford